Molecular analysis of cyclooxigenase gene expression and its application for new designs of anti-inflammatory drug
环加氧酶基因表达的分子分析及其在抗炎药物新设计中的应用
基本信息
- 批准号:11670450
- 负责人:
- 金额:$ 1.86万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
(monocytes/macrophages)CD40 expression of human peripheral blood monocytes (PBMs) was enhanced in the presence of IFN-g, and further induction was achieved by GM-CSF.So far, signaling cascades of CD40 have been examined by using the cells expressing CD40L on their cell membrane. We used anti CD40 antibody as a stimulant, and it was strong enough to induce PBMNs productions of both TNFa and PGE2. These results indicated that CD40 signaling does not need an interaction of other costimulatory molecules. Induced PGE2 production was accompanied by the induction of COX-2 on the level of gene expression. Both MAP Kinases and NFkBwere activated by CD40L-CD40 interaction, although their activation profiles were different from those stimulated by LPS.(neutrophils)In LPS-stimulated human neutrophils, the activation of ERK and p38 MAPK is independently involved in the induction of COX-2 protein, and in PGE2 synthesis. LPS induces the phosphorylation and activation of ERK2 and p38 MAPK in neutrophi … More ls.Both IL-4 and IL-10 completely inhibited LPS-induced COX-2 expression and PGE2 synthesis in neutrophils. Neither of these cytokines alone induced the phosphorylation or activation of these Kinases. Interestingly, IL-10 partly inhibited LPS-induced phosphorylation and activation of p38 MAPK, although IL-4 did not affect LPS-induced phosphorylation or activation of p38 MAPK.In addition, LPS-induced phosphorylation and activation of ERK2 was not affected at all by these cytokines. These results suggest that LPS-induced phosphorylation and activation of p38 MAPK was partly regulated by IL-10, but not by IL-4.Activation of peripheral blood monocytes and neutrophils of patients with rheumatoid arthritis (RA) should be different from those stimulated with LPS in vitro. PGE2 production by RA neutrophils was higher than that by normal neutrophils, and it was chiefly carried out by cyclooxygenase (COX)-2. By using inhibitors for MAP kinase cascade, RA neutrophils showed the activation both of ERK2 and p38 MAPK.IL-4, IL-10 or dexamethasone were able to suppress LPS-induced but not constitutively elevated PGE2 production in RA neutrophils. These results addressed the question that activated condition of RA neutrophils is different from that of neutrophils stimulated by LPS. Less
(单核细胞/巨噬细胞)在IFN-G存在下增强了人外周血单核细胞(PBM)的CD40表达,并且通过在其细胞膜上使用表达CD40L的细胞来检查CD40的信号级联的CD40的信号级联。我们使用抗CD40抗体作为刺激剂,并且足以诱导TNFA和PGE2的PBMNS生产。这些结果表明,CD40信号传导不需要其他共刺激分子的相互作用。通过在基因表达水平上引入COX-2来实现诱导的PGE2产生。 MAP激酶和NFKBWERE都被CD40L-CD40相互作用激活,尽管它们的激活曲线与LPS刺激的激活曲线不同。(中性粒细胞)在LPS刺激的人类嗜中性粒细胞中,ERK和p38 MAPK的激活与Cox-2蛋白质和PGE2综合诱导诱导了Cox-2蛋白质。 LPS在中性粒细胞中诱导ERK2和p38 MAPK的磷酸化和激活……更多的LSS IL-4和IL-10完全抑制了LPS LPS诱导的Cox-COX-COX-COX-COX-COX-2的表达和PGE2中性粒细胞中的PGE2合成。这些细胞因子都没有诱导这些激酶的磷酸化或激活。有趣的是,尽管IL-4不影响LPS诱导的磷酸化或p38 MAPK的激活,但IL-10部分抑制了LPS诱导的p38 MAPK的磷酸化和激活。这些结果表明,LPS诱导的p38 MAPK的磷酸化和激活部分受IL-10的调节,但不通过IL-10调节。4。类风湿关节炎患者的外周血单核细胞和中性粒细胞的激活应与LPS在VITO中刺激的LPS的患者(RA)不同。 RA嗜中性粒细胞产生的PGE2高于正常嗜中性粒细胞的PGE2,首先是通过环氧合酶(COX)-2进行的。通过将抑制剂用于MAP激酶级联反应,RA中性粒细胞显示ERK2和p38 MAPK.IL-4,IL-10或地塞米松都能够抑制LPS诱导的RA中性粒细胞中LPS诱导的PGE2产生。这些结果解决了一个问题,即在LPS刺激的嗜中性粒细胞的RA中性粒细胞的激活状况不同。较少的
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Horiuchi T: "Behcets disease associated with complement component 9 (C9) deficiency."Mod Rheumatol. 10. 276-278 (2000)
Horiuchi T:“与补体成分 9 (C9) 缺乏相关的白塞氏病。”Mod Rheumatol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nemoto Y: "Differential effects of interleukin-4 and interleukin-10 on nitric oxide production by murine macrophages"Inflammation Res. 48. 643-650 (1999)
Nemoto Y:“白细胞介素 4 和白细胞介素 10 对小鼠巨噬细胞产生一氧化氮的不同影响”炎症研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Otsuka T: "Overlap syndrome of polymyositis and progressive systemic sclerosis associated with interferon therapy for chronic hepatitis C"Jpn J Rheumatol. 9・3. 259-265 (1999)
Otsuka T:“与干扰素治疗慢性丙型肝炎相关的多发性肌炎和进行性系统性硬化症的重叠综合征”Jpn J Rheumatol. 259-265 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tanaka Y: "Association of the interferon-γ receptor variant (Vol14 Met) with Systemic Lupus Erythematodes"Immunogenetics. 49・4. 266-271 (1999)
Tanaka Y:“干扰素-γ 受体变体(Vol14 Met)与系统性红斑狼疮的关联”免疫遗传学 49·4(1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Arinobu Y: "Antagonistic effects of an a Hernative splice variant of human IL-4, IL-4δ2, on IL-4 activities in human monocytes and B cells"Cellular Immunology. 191・2. 161-167 (1999)
Arinobu Y:“人 IL-4 的天然剪接变体、IL-4δ2 对人单核细胞和 B 细胞中 IL-4 活性的拮抗作用”《细胞免疫学》191·2。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OTSUKA Takeshi其他文献
OTSUKA Takeshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OTSUKA Takeshi', 18)}}的其他基金
Connection specificity between cortical pyramidal cells and FS interneurons
皮质锥体细胞和 FS 中间神经元之间的连接特异性
- 批准号:
25430019 - 财政年份:2013
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Activity control of inhibitory interneuron networks by pyramidal cells
锥体细胞抑制性中间神经元网络的活动控制
- 批准号:
23700478 - 财政年份:2011
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Connection Specificity in Cortical Circuits
皮层回路的连接特异性
- 批准号:
21700438 - 财政年份:2009
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Molecular analysis of anti-inflammatory effect of IL-10 and IL-4 on monocytes and neutrophils.
IL-10和IL-4对单核细胞和中性粒细胞抗炎作用的分子分析。
- 批准号:
09671120 - 财政年份:1997
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular analysis of anti-inflammatory effect of IL-10 and IL-4 on human monocytes
IL-10和IL-4对人单核细胞抗炎作用的分子分析
- 批准号:
07671213 - 财政年份:1995
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
原位矿化诱导中性粒细胞弹性蛋白酶ELANE介导Notch信号通路增效肺癌放疗的机制研究
- 批准号:82373199
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
中性粒细胞外泌体促胃癌转移机制及转化研究
- 批准号:82372909
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
口腔原虫齿龈阿米巴促进中性粒细胞群集在牙周炎中的分子机制研究
- 批准号:82302553
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
金黄色葡萄球菌定植通过同型半胱氨酸-AKT1-S100A8/A9轴促进慢阻肺中性粒细胞炎症及肺功能下降的机制研究
- 批准号:82300059
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
2型免疫:对上皮损伤的原始反应,形成骨髓和肺髓细胞串扰
- 批准号:
10577950 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Dissecting the Myeloid-Th17 axis in the pathogenesis of Colitis-associated Colorectal Cancer
剖析结肠炎相关结直肠癌发病机制中的骨髓-Th17 轴
- 批准号:
10581383 - 财政年份:2023
- 资助金额:
$ 1.86万 - 项目类别:
Immune function of bitter taste receptors in human macrophages
人巨噬细胞苦味受体的免疫功能
- 批准号:
10418464 - 财政年份:2022
- 资助金额:
$ 1.86万 - 项目类别: